NCT06303713 LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06267729 Study of AZD0754 in Participants With Metastatic Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06177015 Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC Status RECRUITING Phase PHASE3
NCT06112990 Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression Status RECRUITING Phase PHASE3
NCT06062745 Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT Status RECRUITING Phase PHASE1
NCT06040125 Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial Status RECRUITING Phase NA
NCT06009549 A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT05983783 Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC Status RECRUITING Phase PHASE3
NCT05896371 A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05885009 Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) Status RECRUITING Phase N/A
NCT05800665 A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer Status RECRUITING Phase PHASE1
NCT05771896 Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC Status WITHDRAWN Phase PHASE3
NCT05751941 Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer Status RECRUITING Phase PHASE2
NCT05717582 Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT05617885 Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05590793 Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate Status COMPLETED Phase PHASE3
NCT05582772 TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer Status RECRUITING Phase NA